A J.P. Morgan report reveals a growing funding chasm in biopharma, as venture capital flocks to de-risked late-stage companies, forcing early-stage innovators to pivot toward licensing deals and strategic partnerships for survival.
Verizon's aggressive shift to a customer-centric strategy yields its strongest subscriber growth in years, coupled with a massive share repurchase plan, sparking a rally and reigniting investor debate on the telecom giant's value.
BlackRock's Global Infrastructure Partners and Sweden's EQT are nearing a deal to acquire AES Corp., a major renewable energy supplier to tech firms, in a move highlighting the intense investor appetite for power assets amid the AI boom.
Merck & Co. projected 2026 revenue below Wall Street expectations, citing a steeper-than-anticipated impact from patent expirations on key drugs like Januvia. The forecast overshadowed a strong Q4 performance driven by its blockbuster cancer therapy, Keytruda.
Analysts have lifted Man Group's fair value estimate, reflecting a cautiously optimistic recalibration of growth and risk assumptions. The move aligns with a broader trend of upward revisions across the Street, though questions remain about how much future performance is already priced into the stock.
Following a series of strategic asset sales and special dividends, analysts have adopted a more cautious stance on SITE Centers (SITC), adjusting their fair value estimate downward. The revised outlook balances immediate shareholder returns against the long-term prospects of the retailer's streamlined portfolio in a challenging retail real estate landscape.
As cryptocurrency markets navigate a volatile 2026, Ethereum's robust network activity and growing stablecoin adoption position it as a compelling investment opportunity for those looking to deploy modest capital.
In a major move for cost-conscious investors, Vanguard announces sweeping fee reductions across 53 funds, projecting significant savings and reinforcing its client-owned structure amid industry-wide fee pressure.
Amidst a resilient broader market, investors are scouring Europe for overlooked opportunities. We examine three sub-€50 million market cap companies—Componenta, Duell Oyj, and Cherry SE—that combine niche market positions with evolving financial stories, offering potential for growth-oriented portfolios.
Meridian Corporation (NASDAQ: MRBK) announced an increase in its quarterly dividend payout to $0.14 per share, scheduled for February 17. The move comes as the regional bank's stock has surged 30% over the past quarter, though analysts urge caution regarding its long-term earnings trajectory.
With institutional shareholders dominating ownership, Kearny Financial Corp.'s stock trajectory is closely tied to the moves of major funds. While this brings credibility, it also introduces volatility risks that retail investors should watch.
Hanmi Financial Corporation (NASDAQ:HAFC) announced a dividend increase to $0.28 per share, lifting its yield to 4.1%. While the move highlights the bank's strong earnings and cash flow, analysts note its mixed dividend history and the broader challenges facing regional lenders.
Shareholders of both Coeur Mining and New Gold have voted decisively in favor of a merger that will create a major North American precious metals producer, with the deal now awaiting final regulatory approvals.
Natural gas giant EQT Corporation projects a significant $114 million gain from its hedging strategy in Q4 2025, alongside substantial cash settlements. The announcement comes as analysts offer mixed ratings on the Appalachian Basin producer's stock.
As optimism returns to European markets, income-focused investors are turning to dividend stocks for resilience and yield. We analyze three European companies offering compelling payouts, weighing their potential against underlying risks in the current economic climate.
Franklin Resources Inc. (BEN) reported stronger-than-expected Q1 2026 earnings, driven by robust client inflows into its core funds and a surging ETF platform, signaling a successful expansion beyond its traditional fixed-income strengths.
RBC Capital maintains an Outperform rating on Invesco (IVZ) but has lowered its price target to $33, following the asset manager's mixed fourth-quarter earnings. The firm's long-term outlook remains positive, forecasting significant margin expansion driven by operating leverage.
Investment giant BlackRock (BLK) reported better-than-expected fourth-quarter results, highlighted by a 12% annualized organic base-fee growth. UBS responded by raising its price target, though maintains a Neutral stance on the stock.
Western Alliance Bancorporation (WAL) reported quarterly earnings that surpassed analyst expectations, prompting DA Davidson to reaffirm its Buy rating and nudge its price target higher. The bank's performance was driven by strong revenue growth and improved asset quality.
As consumer sentiment sours, investors are pivoting to sectors like financial technology and home construction, anticipating policy moves from Washington aimed at easing cost-of-living pressures before the November elections.
